{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:04:08Z","timestamp":1795089848545,"version":"4.10.2"},"reference-count":79,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:p>The last few years have seen an explosion in clinical research focusing on the use of donor-derived cell-free DNA (dd-cfDNA) in solid-organ transplants (SOT). Although most of the literature published so far focuses on kidney transplants, there are several recent as well as ongoing research studies on heart, lung, pancreas, and liver transplants. Though initially studied as a noninvasive means of identifying subclinical or acute rejection in SOT, it is rapidly becoming clear that instead of being a specific marker for allograft rejection, dd-cfDNA is more appropriately described as a marker of severe injury, although the most common cause of this injury is allograft rejection. Multiple studies in kidney transplants have shown that although sensitivity for the diagnosis of antibody-mediated rejection is excellent, it is less so for T-cell\u2013mediated rejection. It is possible that combining dd-cfDNA with other novel urine- or blood-based biomarkers may increase the sensitivity for the diagnosis of rejection. Irrespective of the cause, though, elevated dd-cfDNA seems to portend adverse allograft prognosis and formation of de novo donor-specific antibody. Although current data do not lend themselves to a clear conclusion, ongoing studies may reveal the utility of serial surveillance for the management of SOT as following levels of dd-cfDNA over time may provide windows of opportunity to intervene early and before irreversible allograft injury. Finally, cost-effectiveness studies will be needed to guide the ideal incorporation of dd-cfDNA into routine clinical practice.<\/jats:p>","DOI":"10.1097\/tp.0000000000003651","type":"journal-article","created":{"date-parts":[[2021,2,8]],"date-time":"2021-02-08T16:54:19Z","timestamp":1612803259000},"page":"1203-1211","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":71,"title":["Donor-derived Cell-free DNA in Solid-organ Transplant Diagnostics: Indications, Limitations, and Future Directions"],"prefix":"10.1097","volume":"105","author":[{"given":"Ashish","family":"Kataria","sequence":"first","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, University of New Mexico, Albuquerque, NM."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhiren","family":"Kumar","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[{"name":"Division of Nephrology, Department of Internal Medicine, Virginia Commonwealth University, Richmond, VA."},{"name":"Department of Internal Medicine, Hume-Lee Transplant Center, Virginia Commonwealth University, Richmond, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,1,27]]},"reference":[{"key":"R1-20250604","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1681\/ASN.2014040399","article-title":"Subclinical rejection phenotypes at 1 year post-transplant and outcome of kidney allografts.","volume":"26","author":"Loupy","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R2-20250604","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1034\/j.1399-0012.1999.130601.x","article-title":"Does subclinical rejection contribute to chronic rejection in renal transplant patients?","volume":"13","author":"Rush","year":"1999","journal-title":"Clin Transplant"},{"key":"R3-20250604","first-page":"854","article-title":"Late acute rejection and subclinical noncompliance with cyclosporine therapy in heart transplant recipients.","volume":"17","author":"De Geest","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"R4-20250604","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1111\/ajt.13387","article-title":"Cell-free DNA: an upcoming biomarker in transplantation.","volume":"15","author":"Gielis","year":"2015","journal-title":"Am J Transplant"},{"key":"R5-20250604","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1373\/jalm.2016.022731","article-title":"Biological variation of donor-derived cell-free DNA in renal transplant recipients: clinical implications.","volume":"2","author":"Bromberg","year":"2019","journal-title":"J Appl Lab Med"},{"key":"R6-20250604","doi-asserted-by":"crossref","first-page":"241ra77","DOI":"10.1126\/scitranslmed.3007803","article-title":"Circulating cell-free DNA enables noninvasive diagnosis of heart transplant rejection.","volume":"6","author":"De Vlaminck","year":"2014","journal-title":"Sci Transl Med"},{"key":"R7-20250604","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1681\/ASN.2016091034","article-title":"Cell-free DNA and active rejection in kidney allografts.","volume":"28","author":"Bloom","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"R8-20250604","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/jcm8010019","article-title":"Optimizing detection of kidney transplant injury by assessment of donor-derived cell-free DNA via massively multiplex PCR.","volume":"8","author":"Sigdel","year":"2018","journal-title":"J Clin Med"},{"key":"R9-20250604","doi-asserted-by":"crossref","first-page":"e1002286","DOI":"10.1371\/journal.pmed.1002286","article-title":"Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: a prospective, observational, multicenter cohort study.","volume":"14","author":"Sch\u00fctz","year":"2017","journal-title":"PLoS Med"},{"key":"R10-20250604","doi-asserted-by":"crossref","first-page":"13336","DOI":"10.1073\/pnas.1517494112","article-title":"Noninvasive monitoring of infection and rejection after lung transplantation.","volume":"112","author":"De Vlaminck","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"R11-20250604","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1111\/ajt.15339","article-title":"Noninvasive detection of graft injury after heart transplant using donor-derived cell-free DNA: a prospective multicenter study.","volume":"19","author":"Khush","year":"2019","journal-title":"Am J Transplant"},{"key":"R12-20250604","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(96)09105-2","article-title":"Microchimerism and rejection in clinical transplantation.","volume":"349","author":"Elwood","year":"1997","journal-title":"Lancet"},{"key":"R13-20250604","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(05)79055-3","article-title":"Presence of donor-specific DNA in plasma of kidney and liver-transplant recipients.","volume":"351","author":"Lo","year":"1998","journal-title":"Lancet"},{"key":"R14-20250604","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/nature15394","article-title":"An integrated map of structural variation in 2,504 human genomes.","volume":"526","author":"Sudmant","year":"2015","journal-title":"Nature"},{"key":"R15-20250604","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jmoldx.2016.07.003","article-title":"Validation of a clinical-grade assay to measure donor-derived cell-free DNA in solid organ transplant recipients.","volume":"18","author":"Grskovic","year":"2016","journal-title":"J Mol Diagn"},{"key":"R16-20250604","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00439-009-0771-1","article-title":"SNPs for a universal individual identification panel.","volume":"127","author":"Pakstis","year":"2010","journal-title":"Hum Genet"},{"key":"R17-20250604","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1097\/TP.0000000000002665","article-title":"Analytical validation of a single-nucleotide polymorphism-based donor-derived cell-free DNA assay for detecting rejection in kidney transplant patients.","volume":"103","author":"Altu\u011f","year":"2019","journal-title":"Transplantation"},{"issue":"Suppl 3","key":"R18-20250604","article-title":"Clinical performance of a donor-derived cell-free DNA assay for detection of rejection in kidney transplant recipients [abstract].","volume":"20","author":"Kleiboeker","year":"2020","journal-title":"Am J Transplant"},{"key":"R19-20250604","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.1097\/TP.0000000000003084","article-title":"Performance of donor-derived cell-free DNA assays in kidney transplant patients.","volume":"104","author":"Grskovic","year":"2020","journal-title":"Transplantation"},{"key":"R20-20250604","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.34067\/KID.0003512020","article-title":"Donor-derived cell free DNA: is it all the same?.","volume":"1","author":"Melancon","year":"2020","journal-title":"Kidney360"},{"key":"R21-20250604","doi-asserted-by":"crossref","first-page":"e0191915","DOI":"10.1371\/journal.pone.0191915","article-title":"Circulating, cell-free DNA as a marker for exercise load in intermittent sports.","volume":"13","author":"Haller","year":"2018","journal-title":"PLoS One"},{"key":"R22-20250604","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1152\/japplphysiol.00002.2014","article-title":"Direct measurement of cell-free DNA from serially collected capillary plasma during incremental exercise.","volume":"117","author":"Breitbach","year":"2014","journal-title":"J Appl Physiol (1985)"},{"key":"R23-20250604","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13075-017-1295-z","article-title":"Circulating DNA in rheumatoid arthritis: pathological changes and association with clinically used serological markers.","volume":"19","author":"Rykova","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"R24-20250604","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1172\/JCI105479","article-title":"Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus.","volume":"45","author":"Tan","year":"1966","journal-title":"J Clin Invest"},{"key":"R25-20250604","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/ajt.15142","article-title":"Diagnostic application of kidney allograft-derived absolute cell-free DNA levels during transplant dysfunction.","volume":"19","author":"Whitlam","year":"2019","journal-title":"Am J Transplant"},{"key":"R26-20250604","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1111\/ajt.15416","article-title":"Absolute quantification of donor-derived cell-free DNA as a marker of rejection and graft injury in kidney transplantation: results from a prospective observational study.","volume":"19","author":"Oellerich","year":"2019","journal-title":"Am J Transplant"},{"key":"R27-20250604","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/clinchem\/hvaa175","article-title":"Time-dependent apparent increase in dd-cfDNA percentage in clinically stable patients between one and five years following kidney transplantation.","volume":"66","author":"Sch\u00fctz","year":"2020","journal-title":"Clin Chem"},{"key":"R28-20250604","article-title":"Diagnostic accuracy of donor-derived cell-free DNA in renal-allograft rejection: a meta-analysis.","author":"Xiao","year":"2020","journal-title":"Transplantation"},{"key":"R29-20250604","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1111\/tri.13753","article-title":"Donor-derived cell-free DNA as a biomarker for rejection after kidney transplantation: a systematic review and meta-analysis.","volume":"33","author":"Wijtvliet","year":"2020","journal-title":"Transpl Int"},{"key":"R30-20250604","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/TP.0000000000003393","article-title":"The monitoring of donor-derived cell-free DNA (ddcfDNA) in kidney transplantation.","volume":"105","author":"Filippone","year":"2021","journal-title":"Transplantation"},{"key":"R31-20250604","doi-asserted-by":"crossref","first-page":"e379","DOI":"10.1097\/TXD.0000000000000821","article-title":"Donor-derived cell-free DNA identifies antibody-mediated rejection in donor specific antibody positive kidney transplant recipients.","volume":"4","author":"Jordan","year":"2018","journal-title":"Transplant Direct"},{"key":"R32-20250604","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3389\/fimmu.2020.00342","article-title":"Diagnostic performance of donor-derived plasma cell-free DNA fraction for antibody-mediated rejection in post renal transplant recipients: a prospective observational study.","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"R33-20250604","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/ajt.15752","article-title":"Discrepancy analysis comparing molecular and histology diagnoses in kidney transplant biopsies.","volume":"20","author":"Madill-Thomsen","year":"2020","journal-title":"Am J Transplant"},{"key":"R34-20250604","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1681\/ASN.2020060915","article-title":"Cell-free DNA: proceed, but with caution.","volume":"31","author":"Crew","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"R35-20250604","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1111\/ajt.15289","article-title":"Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients.","volume":"19","author":"Huang","year":"2019","journal-title":"Am J Transplant"},{"key":"R36-20250604","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/TP.0000000000002560","article-title":"The impact of early clinical and subclinical T cell-mediated rejection after kidney transplantation.","volume":"103","author":"Hoffman","year":"2019","journal-title":"Transplantation"},{"key":"R37-20250604","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1111\/ajt.15197","article-title":"The clinical and pathological significance of borderline T cell-mediated rejection.","volume":"19","author":"Nankivell","year":"2019","journal-title":"Am J Transplant"},{"key":"R38-20250604","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1600-6143.2011.03784.x","article-title":"The nature of biopsies with \u201cborderline rejection\u201d and prospects for eliminating this category.","volume":"12","author":"de Freitas","year":"2012","journal-title":"Am J Transplant"},{"key":"R39-20250604","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1111\/ajt.15822","article-title":"High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury.","volume":"20","author":"Stites","year":"2020","journal-title":"Am J Transplant"},{"key":"R40-20250604","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1097\/TP.0000000000001163","article-title":"Subclinical rejection in renal transplantation: reappraised.","volume":"100","author":"Mehta","year":"2016","journal-title":"Transplantation"},{"key":"R41-20250604","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/ajt.15011","article-title":"Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant.","volume":"19","author":"Friedewald","year":"2019","journal-title":"Am J Transplant"},{"key":"R42-20250604","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/ndt\/gfz091","article-title":"The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney transplantation.","volume":"35","author":"Gielis","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"R43-20250604","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1097\/01.tp.0000225783.86950.c2","article-title":"Treatment of subclinical rejection diagnosed by protocol biopsy of kidney transplants.","volume":"82","author":"Kee","year":"2006","journal-title":"Transplantation"},{"key":"R44-20250604","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/ajt.16150","article-title":"Economic analysis of screening for subclinical rejection in kidney transplantation using protocol biopsies and noninvasive biomarkers.","volume":"21","author":"Puttarajappa","year":"2021","journal-title":"Am J Transplant"},{"key":"R45-20250604","doi-asserted-by":"crossref","first-page":"e920839","DOI":"10.12659\/AOT.920839","article-title":"Serial peripheral blood gene expression profiling to assess immune quiescence in kidney transplant recipients with stable renal function.","volume":"25","author":"Peddi","year":"2020","journal-title":"Ann Transplant"},{"key":"R46-20250604","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1111\/ajt.12426","article-title":"Multicenter validation of urinary CXCL9 as a risk-stratifying biomarker for kidney transplant injury.","volume":"13","author":"Hricik","year":"2013","journal-title":"Am J Transplant"},{"key":"R47-20250604","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1215555","article-title":"Urinary-cell mRNA profile and acute cellular rejection in kidney allografts.","volume":"369","author":"Suthanthiran","year":"2013","journal-title":"N Engl J Med"},{"key":"R48-20250604","doi-asserted-by":"crossref","first-page":"e14053","DOI":"10.1111\/ctr.14053","article-title":"Prognostic value of the donor-derived cell-free DNA assay in acute renal rejection therapy: a prospective cohort study.","volume":"34","author":"Shen","year":"2020","journal-title":"Clin Transplant"},{"key":"R49-20250604","doi-asserted-by":"crossref","first-page":"e0208207","DOI":"10.1371\/journal.pone.0208207","article-title":"Plasma donor-derived cell-free DNA kinetics after kidney transplantation using a single tube multiplex PCR assay.","volume":"13","author":"Gielis","year":"2018","journal-title":"PLoS One"},{"key":"R50-20250604","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/TP.0000000000002482","article-title":"Donor-specific cell-free DNA as a biomarker in solid organ transplantation: a systematic review.","volume":"103","author":"Knight","year":"2019","journal-title":"Transplantation"},{"key":"R51-20250604","doi-asserted-by":"crossref","first-page":"e568","DOI":"10.1097\/TXD.0000000000001019","article-title":"Donor-derived cell-free DNA in infections in kidney transplant recipients: case series.","volume":"6","author":"Goussous","year":"2020","journal-title":"Transplant Direct"},{"key":"R52-20250604","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1097\/TP.0000000000002579","article-title":"Donor-derived cell-free DNA may confirm real-time response to treatment of acute rejection in renal transplant recipients.","volume":"103","author":"Hinojosa","year":"2019","journal-title":"Transplantation"},{"key":"R53-20250604","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9051480","article-title":"The use of donor-derived cell-free DNA for assessment of allograft rejection and injury status.","volume":"9","author":"Thongprayoon","year":"2020","journal-title":"J Clin Med"},{"key":"R54-20250604","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/ajt.15192","article-title":"Repeat kidney transplant recipients with active rejection have elevated donor-derived cell-free DNA.","volume":"19","author":"Mehta","year":"2019","journal-title":"Am J Transplant"},{"key":"R55-20250604","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/tri.13673","article-title":"Impact of kidney transplant type and previous transplant on baseline donor-derived cell free DNA.","volume":"33","author":"Sureshkumar","year":"2020","journal-title":"Transpl Int"},{"key":"R56-20250604","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/ajt.12167","article-title":"Acute pancreas allograft rejection is associated with increased risk of graft failure in pancreas transplantation.","volume":"13","author":"Dong","year":"2013","journal-title":"Am J Transplant"},{"key":"R57-20250604","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1111\/ajt.12443","article-title":"Acute cellular and antibody-mediated rejection of the pancreas allograft: incidence, risk factors and outcomes.","volume":"13","author":"Niederhaus","year":"2013","journal-title":"Am J Transplant"},{"key":"R58-20250604","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1373\/clinchem.2005.058974","article-title":"Soluble donor DNA concentrations in recipient serum correlate with pancreas-kidney rejection.","volume":"52","author":"Gadi","year":"2006","journal-title":"Clin Chem"},{"issue":"Suppl 3","key":"R59-20250604","article-title":"Donor-derived cell-free DNA for surveillance in simultaneous pancreas and kidney transplant recipients, can we extrapolate from kidney transplant alone?","volume":"19","author":"Olaitan","year":"2019","journal-title":"Am J Transplant"},{"key":"R60-20250604","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.transproceed.2015.08.035","article-title":"Donor-derived cell-free DNA is a novel universal biomarker for allograft rejection in solid organ transplantation.","volume":"47","author":"Beck","year":"2015","journal-title":"Transplant Proc"},{"key":"R61-20250604","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.pathol.2017.08.004","article-title":"The value of endomyocardial biopsy in diagnosis and guiding therapy.","volume":"49","author":"Khan","year":"2017","journal-title":"Pathology"},{"issue":"1 Pt 1","key":"R62-20250604","first-page":"63","article-title":"Complications of endomyocardial biopsy in heart transplant patients.","volume":"12","author":"Baraldi-Junkins","year":"1993","journal-title":"J Heart Lung Transplant"},{"key":"R63-20250604","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.healun.2017.05.029","article-title":"Building a tissue-based molecular diagnostic system in heart transplant rejection: the heart Molecular Microscope Diagnostic (MMDx) System.","volume":"36","author":"Halloran","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R64-20250604","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.echo.2017.06.003","article-title":"Multimodality noninvasive imaging in the monitoring of pediatric heart transplantation.","volume":"30","author":"Kindel","year":"2017","journal-title":"J Am Soc Echocardiogr"},{"key":"R65-20250604","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5500\/wjt.v6.i4.751","article-title":"Magnetic resonance imaging of the transplanted pediatric heart as a potential predictor of rejection.","volume":"6","author":"Greenway","year":"2016","journal-title":"World J Transplant"},{"key":"R66-20250604","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.healun.2019.11.015","article-title":"Donor fraction cell-free DNA and rejection in adult and pediatric heart transplantation.","volume":"39","author":"Richmond","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R67-20250604","first-page":"47","article-title":"Circulating donor-derived cell-free DNA: a true biomarker for cardiac allograft rejection?","volume":"3","author":"Daly","year":"2015","journal-title":"Ann Transl Med"},{"key":"R68-20250604","doi-asserted-by":"crossref","first-page":"6229","DOI":"10.1073\/pnas.1013924108","article-title":"Universal noninvasive detection of solid organ transplant rejection.","volume":"108","author":"Snyder","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R69-20250604","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-6143.2005.01175.x","article-title":"Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling.","volume":"6","author":"Deng","year":"2006","journal-title":"Am J Transplant"},{"key":"R70-20250604","doi-asserted-by":"crossref","first-page":"15366","DOI":"10.1038\/s41598-018-33848-3","article-title":"Donor-derived cell-free DNA is associated with acute rejection and decreased oxygenation in primary graft dysfunction after living donor-lobar lung transplantation.","volume":"8","author":"Tanaka","year":"2018","journal-title":"Sci Rep"},{"key":"R71-20250604","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ebiom.2018.12.029","article-title":"Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation.","volume":"40","author":"Agbor-Enoh","year":"2019","journal-title":"Ebiomedicine"},{"key":"R72-20250604","first-page":"201","article-title":"Cell-free DNA as a measure of transplant injury.","author":"Sigdel","year":"2012","journal-title":"Clin Transpl"},{"key":"R73-20250604","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1097\/TXD.0000000000001061","article-title":"Donor-derived cell-free DNA and the prediction of BK virus-associated nephropathy.","volume":"6","author":"Kant","year":"2020","journal-title":"Transplant Direct"},{"key":"R74-20250604","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1097\/TXD.0000000000001027","article-title":"Donor-derived cell-free DNA combined with histology improves prediction of estimated glomerular filtration rate over time in kidney transplant recipients compared with histology alone.","volume":"6","author":"Huang","year":"2020","journal-title":"Transplant Direct"},{"key":"R75-20250604","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1097\/TP.0000000000003240","article-title":"Adding insult on injury: immunogenic role for donor-derived cell-free DNA?","volume":"104","author":"Dholakia","year":"2020","journal-title":"Transplantation"},{"key":"R76-20250604","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.kint.2016.12.024","article-title":"Posttransplant peripheral blood donor-specific interferon-\u03b3 enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.","volume":"92","author":"Crespo","year":"2017","journal-title":"Kidney Int"},{"key":"R77-20250604","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/MOT.0000000000000193","article-title":"The molecular phenotypes of rejection in kidney transplant biopsies.","volume":"20","author":"Halloran","year":"2015","journal-title":"Curr Opin Organ Transplant"},{"key":"R78-20250604","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/ajt.15178","article-title":"Molecular phenotype of kidney transplant indication biopsies with inflammation in scarred areas.","volume":"19","author":"Halloran","year":"2019","journal-title":"Am J Transplant"},{"key":"R79-20250604","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1111\/ajt.14329","article-title":"Real time central assessment of kidney transplant indication biopsies by microarrays: the INTERCOMEX study.","volume":"17","author":"Halloran","year":"2017","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003651","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T19:17:33Z","timestamp":1749064653000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000003651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,27]]},"references-count":79,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000003651","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,27]]}}}